Latest Insider Transactions at Staar Surgical CO (STAA)
This section provides a real-time view of insider transactions for Staar Surgical CO (STAA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STAAR SURGICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STAAR SURGICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2020
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
18,959
+11.93%
|
$208,549
$11.45 P/Share
|
|
Nov 23
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Open market or private sale
|
Direct |
4,774
-2.13%
|
$396,242
$83.08 P/Share
|
|
Nov 23
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.65%
|
$28,500
$15.54 P/Share
|
|
Nov 20
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Open market or private sale
|
Direct |
2,688
-2.36%
|
$223,104
$83.02 P/Share
|
|
Nov 19
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Open market or private sale
|
Direct |
14,007
-10.95%
|
$1,148,574
$82.03 P/Share
|
|
Nov 19
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
SELL
Exercise of conversion of derivative security
|
Direct |
12,156
-8.68%
|
$996,792
$82.02 P/Share
|
|
Nov 19
2020
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
12,156
+7.98%
|
$182,340
$15.54 P/Share
|
|
Nov 16
2020
|
Scott D Barnes Chief Medical Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
22,593
-52.56%
|
$1,807,440
$80.25 P/Share
|
|
Nov 16
2020
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,593
+22.96%
|
$722,976
$32.89 P/Share
|
|
Nov 09
2020
|
Keith Holliday Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
23,714
-40.85%
|
$1,920,834
$81.56 P/Share
|
|
Nov 09
2020
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,714
+28.03%
|
$309,712
$8.41 P/Share
|
|
Nov 09
2020
|
Jon K. Hayashida VP, Global Clinical, Medical |
SELL
Open market or private sale
|
Direct |
20,000
-64.95%
|
$1,620,000
$81.34 P/Share
|
|
Nov 09
2020
|
Jon K. Hayashida VP, Global Clinical, Medical |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+28.42%
|
$440,000
$22.97 P/Share
|
|
Nov 09
2020
|
John C Moore Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
14,254
-55.59%
|
$1,140,320
$80.88 P/Share
|
|
Nov 09
2020
|
John C Moore Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,206
-88.45%
|
$1,312,686
$81.03 P/Share
|
|
Nov 09
2020
|
John C Moore Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,206
+28.11%
|
$226,884
$14.06 P/Share
|
|
Jul 01
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Jul 01
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
4,062
-0.04%
|
-
|
|
Jan 21
2020
|
K Peony Yu Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+50.0%
|
-
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Jan 02
2020
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
41,220
-0.38%
|
-
|
|
May 03
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
May 03
2019
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+0.91%
|
$2,200,000
$22.23 P/Share
|
|
Oct 01
2018
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
|
Oct 01
2018
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
114,549
-1.06%
|
-
|